BC
DGX icon

Brookfield Corp’s Quest Diagnostics DGX Stock Holding History

Brookfield Corp’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,911
Closed -$5.47M – 226
2023
Q2 		$5.47M Sell
38,911
-8,598
-18% -$1.19M 0.02% 253
2023
Q1 		$6.72M Buy
47,509
+11,371
+31% +$1.63M 0.03% 241
2022
Q4 		$5.65M Buy
+36,138
New +$5.19M 0.02% 243
2020
Q3 		– Sell
-12,768
Closed -$1.46M – 393
2020
Q2 		$1.46M Buy
+12,768
New +$1.35M 0.01% 256

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Brookfield Corp's DGX Position: Q3 2023 in Review

Brookfield Corp sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 38,911 shares — an estimated $5.47M sold.

Brookfield Corp first reported a position in DGX in Q2 2020 and held it in 4 quarters. The position peaked at $6.72M in Q1 2023. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Brookfield Corp reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 38,911 Quest Diagnostics shares in Q3 2023, an estimated $5.47M.
  • Brookfield Corp first reported a position in Quest Diagnostics in Q2 2020 and held it in 4 quarters.
  • Brookfield Corp's Quest Diagnostics position peaked at $6.72M in Q1 2023.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.